Luke O’Neill, Trinity Biomedical Sciences Institute, Trinity College Dublin, The University of Dublin, Ireland
Luke O’Neill

Professor Luke O’Neill holds the Chair of Biochemistry at Trinity College Dublin where he leads the Inflammation Research Group. He has a PhD in Pharmacology from the University of London and carried out Post-Doctoral research at Cambridge U.K. His research is in the area of the molecular basis to inflammation with a particular focus on innate immunity, Toll-like receptors, inflammasomes and metabolic reprogramming in macrophage activation. In 2016 he was named by Clarivates/Thompson Reuters as one of the world’s most influential scientists, being in the top 1% in Immunology. He is co-founder of 2 Spin-out companies -  Opsona Therapeutics and Inflazome, which is developing new treatments for inflammatory diseases.  He was elected a Fellow of the Royal Society in 2016. 

« Go Back

Register Here Submit Abstract
Supporting Publications
Elsevier Family Support Awards